Rosetta Genomics Picks Up Pacific Rim Distributor | GenomeWeb

NEW YORK (GenomeWeb News) – Genetic Technologies will distribute Rosetta Genomics' cancer diagnostic tests in Australia, New Zealand, and Singapore, under an exclusive agreement announced by Rosetta Genomics today.

GTG, a Melbourne-based genetic testing lab, will market the company's microRNA-based miRview tests in the three countries, Rosetta Genomics said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.